Particle.news
Download on the App Store
3 ARTICLES
·
2d ago

Bristol-Myers Squibb Faces 33% Q2 EPS Drop as Dividend Holds at 5.2%

Analysts predict EPS will fall to $1.38 in the July 31 report, driven by patent expirations coupled with currency headwinds

Image
Image

Overview

  • The board approved a quarterly dividend of $0.62 per share on June 17, marking the 16th straight annual increase and delivering a 5.2% yield.
  • Strong liquidity underpins the payout, with cash and equivalents rising to $10.8 billion at the end of Q1 2025 from $10.3 billion six months earlier.
  • First-quarter revenue reached $11.2 billion, down 5.6% year over year but surpassing analyst forecasts by nearly $495 million.
  • Ahead of its July 31 earnings release, analysts forecast Q2 EPS of $1.38, representing a 33% decline from $2.07 in the year-ago quarter.
  • Full-year EPS is projected to climb to $6.56 in 2025 before easing to $6.03 in 2026 as patent cliffs and currency headwinds weigh on margins.